What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy
What You Should Know:
- Babyscripts today announced a commercial partnership with
Roche Diagnostics, a division of the world’s largest biotech company and a
global pioneer in pharmaceuticals and diagnostics.
- Roche will partner with Babyscripts on the
development of Babyscripts’ remote patient monitoring (RPM) programs to
leverage groundbreaking data science through the next generation of RPM in
pregnancy.
Babyscripts, a
Washington D.C.-based
Read More
Corindus Vascular Robotics CEO Departure, UPMC Enterprises’ New President, Nordic Consulting’s New CIO, Other Health IT Hires
Mark Toland, Partner, Biostar Capital
Mark Toland, CEO of Corindus Vascular Robotics (acquired by Siemens for $1.1B last year), has announced his departure and will be joining BioStar Capital, a health-tech venture capital group focused on cardiovascular and orthopedic medical devices. As a partner and entrepreneur in residence, Mark will help to identify and develop innovative companies leveraging AI, deep learning, robotics, and other transformative technologies that address a wide range of
Read More
Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments
Evidation, Co-CEO, Christine Lemke
Evidation’s Board of Directors has appointed Christine Lemke as Co-CEO alongside Executive Chair Deborah Kilpatrick.
Pratap Sarker, President, Greenway Health
Greenway Health appoints Pratap Sarker as President to oversee all commercial and customer-focused functions including sales, marketing, and customer success. He will also work closely with Greenway’s clearinghouse, revenue cycle and IT teams to ensure the delivery of quality solutions
Read More
FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes
What You Should Know:
- Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system.
- The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
2020 MedTech Breakthrough Award Winners Announced
What You Should Know:
- MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today.
- The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services.
MedTech
Breakthrough, a market intelligence organization that
Read More
In-Depth: 32 FDA-Approved COVID-19 Testing Kits
What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?
On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market:
- The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio.
- TeraRecon is an Advanced
Read More
Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).The Cancer Genome Atlas (TCGA) Project BackgroundThere are 230 distinct investigators that contributed
Read More
